Avalo Therapeutics Inc. (AVTX)
Avalo Therapeutics Statistics
Share Statistics
Avalo Therapeutics has 10.83M shares outstanding. The number of shares has increased by 931.97% in one year.
| 10.83M |
| 931.97% |
| 1.99% |
| 61.5% |
| n/a |
| 73 |
| 0.09% |
Short Selling Information
The latest short interest is 86.49K, so 0.8% of the outstanding shares have been sold short.
| 86.49K |
| 0.8% |
| 0.81% |
| 1.61 |
Valuation Ratios
The PE ratio is -1.72 and the forward PE ratio is -0.87. Avalo Therapeutics's PEG ratio is 0.02.
| -1.72 |
| -0.87 |
| 136.95 |
| 3.1 |
| 0.45 |
| -1.23 |
| 0.02 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Avalo Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 19.96, with a Debt / Equity ratio of 0.
| 19.96 |
| 19.96 |
| 0 |
| -0.01 |
| -0.01 |
| -20.65 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $19,173.91 |
| $-1,527,347.83 |
| 23 |
| 0 |
| n/a |
Taxes
| 114K |
| -0.33% |
Stock Price Statistics
The stock price has increased by -61.15% in the last 52 weeks. The beta is 0.71, so Avalo Therapeutics's price volatility has been higher than the market average.
| 0.71 |
| -61.15% |
| 4.95 |
| 8.1 |
| 50.07 |
| 78,811 |
Income Statement
In the last 12 months, Avalo Therapeutics had revenue of 441K and earned -35.13M in profits. Earnings per share was -4.32.
| 441K |
| -26.83M |
| -68.51M |
| -35.13M |
| -68.51M |
| -31.7M |
| -4.32 |
Balance Sheet
The company has 134.55M in cash and 568K in debt, giving a net cash position of 133.98M.
| 134.55M |
| 568K |
| 133.98M |
| -370.26M |
| 138.52M |
| 121.33M |
Cash Flow
In the last 12 months, operating cash flow was -49.06M and capital expenditures 0, giving a free cash flow of -49.06M.
| -49.06M |
| n/a |
| -49.06M |
| -6.04 |
Margins
Gross margin is -6084.81%, with operating and profit margins of -15535.6% and -7965.76%.
| -6084.81% |
| -15535.6% |
| -7939.91% |
| -7965.76% |
| -15535.6% |
| -15535.6% |
| -11123.81% |
Dividends & Yields
AVTX does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for AVTX is $30, which is 602.6% higher than the current price. The consensus rating is "Buy".
| $30 |
| 602.6% |
| Buy |
| 6 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Dec 29, 2023. It was a backward split with a ratio of 1:240.
| Dec 29, 2023 |
| backward |
| 1:240 |
Scores
| -2.49 |
| 3 |